Carmat SA (ALCAR.PA)
EUR 1.0
(-1.09%)
EUR 1.0
(-1.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 21.54 Million EUR | 2740.88% |
| 2022 | -2.09 Million EUR | -126.38% |
| 2021 | 7.93 Million EUR | -50.59% |
| 2020 | 16.06 Million EUR | -61.04% |
| 2019 | 41.24 Million EUR | -1.47% |
| 2018 | 41.86 Million EUR | 38.1% |
| 2017 | 30.31 Million EUR | 112.03% |
| 2016 | 14.29 Million EUR | 33.77% |
| 2015 | 10.68 Million EUR | 3549.88% |
| 2014 | 292.81 Thousand EUR | -89.31% |
| 2013 | 2.74 Million EUR | -53.7% |
| 2012 | 5.91 Million EUR | 4488.66% |
| 2011 | -134.84 Thousand EUR | -103.11% |
| 2010 | 4.34 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 28.7 Million EUR | 0.0% |
| 2023 Q2 | 8.24 Million EUR | 0.0% |
| 2023 Q4 | 47.84 Million EUR | 0.0% |
| 2023 FY | 55.3 Million EUR | 2740.88% |
| 2022 FY | -2.09 Million EUR | -126.38% |
| 2022 Q2 | -2.53 Million EUR | 0.0% |
| 2022 Q4 | 441 Thousand EUR | 0.0% |
| 2021 Q4 | 5.73 Million EUR | 0.0% |
| 2021 FY | 7.93 Million EUR | -50.59% |
| 2021 Q2 | 24.97 Million EUR | 0.0% |
| 2020 Q4 | 8.29 Million EUR | 0.0% |
| 2020 Q2 | 20.1 Million EUR | 0.0% |
| 2020 FY | 16.06 Million EUR | -61.04% |
| 2019 Q2 | 23.09 Million EUR | 0.0% |
| 2019 Q4 | 18.14 Million EUR | 0.0% |
| 2019 FY | 41.24 Million EUR | -1.47% |
| 2018 FY | 41.86 Million EUR | 38.1% |
| 2018 Q2 | 5.74 Million EUR | 0.0% |
| 2018 Q4 | 23.12 Million EUR | 0.0% |
| 2017 Q2 | 4.05 Million EUR | 0.0% |
| 2017 FY | 30.31 Million EUR | 112.03% |
| 2017 Q4 | 5.13 Million EUR | 0.0% |
| 2016 Q2 | 3.08 Million EUR | 0.0% |
| 2016 FY | 14.29 Million EUR | 33.77% |
| 2016 Q4 | 3.84 Million EUR | 0.0% |
| 2015 FY | 10.68 Million EUR | 3549.88% |
| 2015 Q4 | 3.4 Million EUR | 0.0% |
| 2015 Q2 | 3.04 Million EUR | 0.0% |
| 2014 FY | 292.81 Thousand EUR | -89.31% |
| 2014 Q2 | 2.83 Million EUR | 0.0% |
| 2014 Q4 | 3.14 Million EUR | 0.0% |
| 2013 Q1 | 685.06 Thousand EUR | 0.0% |
| 2013 Q4 | 2.62 Million EUR | 283.28% |
| 2013 FY | 2.74 Million EUR | -53.7% |
| 2013 Q3 | 685.06 Thousand EUR | -77.14% |
| 2013 Q2 | 2.99 Million EUR | 337.46% |
| 2012 Q4 | 685.06 Thousand EUR | -53.7% |
| 2012 Q1 | 1.47 Million EUR | 0.0% |
| 2012 FY | 5.91 Million EUR | 4488.66% |
| 2012 Q3 | 1.47 Million EUR | 0.0% |
| 2012 Q2 | 1.47 Million EUR | 0.0% |
| 2011 Q1 | -33.71 Thousand EUR | 0.0% |
| 2011 Q3 | -33.71 Thousand EUR | 0.0% |
| 2011 Q4 | 1.47 Million EUR | 4488.66% |
| 2011 FY | -134.84 Thousand EUR | -103.11% |
| 2011 Q2 | -33.71 Thousand EUR | 0.0% |
| 2010 FY | 4.34 Million EUR | 0.0% |
| 2010 Q4 | -33.71 Thousand EUR | -103.11% |
| 2010 Q1 | 1.08 Million EUR | 0.0% |
| 2010 Q3 | 1.08 Million EUR | 0.0% |
| 2010 Q2 | 1.08 Million EUR | 0.0% |
| 2009 Q4 | 1.08 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Affluent Medical SA | 11.86 Million EUR | -81.594% |
| Bluelinea Société Anonyme | 11.43 Thousand EUR | -188273.11% |
| Diagnostic Medical Systems S.A. | 18.1 Million EUR | -18.997% |
| Euromedis Groupe | 17.6 Million EUR | -22.368% |
| Eurobio Scientific Société anonyme | 47.34 Million EUR | 54.489% |
| Ikonisys S.A. | 2.44 Million EUR | -779.67% |
| Implanet S.A. | 9.29 Million EUR | -131.923% |
| Median Technologies SA | 46.34 Million EUR | 53.502% |
| SpineGuard SA | 7.35 Million EUR | -192.965% |
| Theraclion SA | -1.08 Million EUR | 2094.474% |
| Euroapi S.A. | 398.9 Million EUR | 94.598% |
| Guerbet SA | 550.79 Million EUR | 96.088% |
| Ion Beam Applications SA | 128.02 Million EUR | 83.169% |
| Koninklijke Philips N.V. | 5.84 Billion EUR | 99.631% |
| Sequana Medical NV | 30.03 Million EUR | 28.268% |